Friday, April 15, 2016

BRIEF-21st Century Oncology Holdings Inc expects FY pro forma adjusted EBITDA of $155-$170 million

* Expects to report PRO FORMA adjusted EBITDA of between

$155 million and $170 million for year ended December 31, 2015

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)